Tigermed
Meihua Q. has extensive work experience in the pharmaceutical and clinical research industry. Meihua currently holds the position of Director of Statistics at Tigermed since April 2023. Before that, they worked as the Director of Statistics at Immunovant from November 2022 to April 2023. Prior to that, Meihua Q. was associated with Tigermed, where they held the roles of Director from July 2022 to November 2022 and Associate Director from June 2019 to June 2022. Meihua Q. also worked as a Principal Statistician at Syneos Health Clinical Solutions from October 2010 to June 2019 and as a Project Statistician at Eli Lilly and Company from January 2002 to October 2010.
Meihua Q. has studied at The University of Georgia, where they earned a Master of Science degree in Statistics. Additionally, they pursued a Doctor of Philosophy degree at The University of Georgia.
This person is not in any offices
Tigermed
1 followers
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.